Editorial Board
Ruman Rahman PhD Molecular and Cellular Biology (University of Edinburgh Roslin Institute); BSc Genetics (University of Edinburgh)
Professor of Molecular Neuro-Oncology, University of Nottingham, Nottingham, England · United Kingdom
Editorial leadership for Journal of Advanced Therapeutic Science
Research interests
- Eomere
- Telomerase Pathways With Respect To Childhood Brain Cancer Progression
Biography
- After graduating with a BSc in Genetics at the University of Edinburgh, I completed a PhD in Molecular Biology at the Roslin Institute, Edinburgh under the supervision of Sir Ian Wilmut in 2007.
- I joined Professor Richard Grundy's laboratory at the Children's Brain Tumour Research Centre, University of Nottingham as a Post-Doctoral Research Associate in 2007 and received the Nottingham Advanced Research Fellowship for the Faculty of Medicine in 2011.
- I am currently an Assistant Professor in Molecular Neuro-Oncology at the University of Nottingham and lead research programmes in intracranial drug delivery, 3D brain tumour models and tumour heterogeneity.
Selected publications
- Etoposide and olaparib polymer-coated nanoparticles within a bioadhesive sprayable hydrogel for post-surgical localised delivery to brain tumours 2020 cited 64×
- The Invasive Region of Glioblastoma Defined by 5ALA Guided Surgery Has an Altered Cancer Stem Cell Marker Profile Compared to Central Tumour 2017 cited 58×
- Wireless electrical–molecular quantum signalling for cancer cell apoptosis 2023 cited 46×
- Overall Survival in Malignant Glioma Is Significantly Prolonged by Neurosurgical Delivery of Etoposide and Temozolomide from a Thermo-Responsive Biodegradable Paste 2019 cited 45×
- Toward Hijacking Bioelectricity in Cancer to Develop New Bioelectronic Medicine 2021 cited 44×
- Using Light for Therapy of Glioblastoma Multiforme (GBM) 2020 cited 41×
Ranked by citation impact (Crossref) where available, newest otherwise · verified via ORCID.
Considering JATS for your work?
This journal is guided by Ruman Rahman (Professor of Molecular Neuro-Oncology, University of Nottingham, Nottingham, England) and a peer-review board of practising researchers. Open access, author-retained copyright (CC BY), and a clear editorial process.